Home › Metabolic Disorders › Washington › Seattle
Metabolic Disorders clinical trials in Seattle, WA
4 studies for Metabolic Disorders are looking for participants at sites in and around Seattle (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
METabolic MODulation to Enhance Insulin Sensitivity and Mitochondrial Function in Type 1 Diabetes (MetMod-T1D)
RecruitingPhase 2
- University of Washington Medicine Diabetes Institute (UWMDI), Seattle
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
RecruitingPhase 3
- 89bio Clinical Study Site, Seattle
- 89bio Clinical Study Site, Seattle
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
RecruitingPhase 3
- 89bio Clinical Study Site, Seattle
- 89bio Clinical Study Site, Seattle
Rare and Atypical Diabetes Network
RecruitingObservational study
- University of Washington, Seattle
About Metabolic Disorders
Your metabolism makes energy from the food you eat. A metabolic disorder disrupts this process. One example is diabetes. Learn more.
More about Metabolic Disorders on MedlinePlus
Metabolic Disorders trials in other cities
- Washington, DC11 studies
- Ann Arbor, MI8 studies
- New York City, NY7 studies
- St. Louis, MO7 studies
- Durham, NC7 studies
- Houston, TX6 studies
- Baltimore, MD6 studies
- Chicago, IL6 studies
- Boston, MA5 studies
- Los Angeles, CA4 studies
- Miami, FL4 studies
- Nashville, TN4 studies
Other studies in Seattle
- Non-Small Cell Lung Cancer53 studies
- Cancer (all types)49 studies
- Prostate Cancer42 studies
- Acute Myeloid Leukemia40 studies
- Breast Cancer39 studies
- Metastatic Cancer39 studies
- Colorectal Cancer34 studies
- Lung Cancer33 studies
- Ovarian Cancer30 studies
- Multiple Myeloma22 studies
- Myelodysplastic Syndromes21 studies
- Acute Lymphoblastic Leukemia21 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.